Noven Pharmaceuticals Inc. is recalling 3,977 boxes of Daytrana (methylphenidate transdermal system) 15 mg patches because they do not meet quality standards for adhesive properties. The recalled patches, which are used to treat ADHD, were found to be out of specification for "shear," a technical measure of how well the patch sticks. If you have any health concerns or questions about your medication, you should contact your doctor or pharmacist.
The patch adhesive may fail, which can cause the patch to detach from the skin or lead to inconsistent delivery of the medication. This could result in the patient receiving an incorrect dose of methylphenidate.
You have 2 options:
Recall #: D-0071-2023; Manufactured for Noven Therapeutics, LLC and By Noven Pharmaceuticals, Inc.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.